Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Emma

Showing results (171-180 of 225) with videos related to

Pageof 23
Sort By:
Nature Reviews. Nephrology|May 10, 2019
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemiaDieter Haffner, Francesco Emma, Deborah M Eastwood, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
Nephropathic cystinosis: an international consensus documentFrancesco Emma, Galina Nesterova, Craig Langman, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2020
Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic CystinosisEster De Leo, Mohamed A Elmonem, Sante Princiero Berlingerio, et al.
Therapeutic Advances in Chronic Disease|September 9, 2022
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and descriptionMaria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 21, 2025
A novel, dominant disease mechanism of distal renal tubular acidosis with specific variants in ATP6V1B1Myrte Daenen, Marguerite Hureaux, Emma Ashton, et al.
Kidney International|September 12, 2020
Cystinuria: clinical practice recommendationAude Servais, Kay Thomas, Luca Dello Strologo, et al.
Orphanet Journal of Rare Diseases|February 3, 2025
XLH Matters: an evolving programme to discuss new advances and share clinical experiences to improve patient outcomesLothar Seefried, Ferdinando Aliberti, Cathrine Alsaker Heier, et al.
Kidney International|October 22, 2017
A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndromeMariken P Gruppen, Antonia H Bouts, Marijke C Jansen-van der Weide, et al.
Kidney International|November 5, 2020
Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in childrenAntonio Gargiulo, Laura Massella, Barbara Ruggiero, et al.
Therapeutic Advances in Chronic Disease|May 20, 2024
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysisAnnemieke M Boot, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Pageof 23

Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
Nature Reviews. Nephrology|May 10, 2019
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemiaDieter Haffner, Francesco Emma, Deborah M Eastwood, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
Nephropathic cystinosis: an international consensus documentFrancesco Emma, Galina Nesterova, Craig Langman, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2020
Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic CystinosisEster De Leo, Mohamed A Elmonem, Sante Princiero Berlingerio, et al.
Therapeutic Advances in Chronic Disease|September 9, 2022
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and descriptionMaria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 21, 2025
A novel, dominant disease mechanism of distal renal tubular acidosis with specific variants in ATP6V1B1Myrte Daenen, Marguerite Hureaux, Emma Ashton, et al.
Kidney International|September 12, 2020
Cystinuria: clinical practice recommendationAude Servais, Kay Thomas, Luca Dello Strologo, et al.
Orphanet Journal of Rare Diseases|February 3, 2025
XLH Matters: an evolving programme to discuss new advances and share clinical experiences to improve patient outcomesLothar Seefried, Ferdinando Aliberti, Cathrine Alsaker Heier, et al.
Kidney International|October 22, 2017
A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndromeMariken P Gruppen, Antonia H Bouts, Marijke C Jansen-van der Weide, et al.
Kidney International|November 5, 2020
Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in childrenAntonio Gargiulo, Laura Massella, Barbara Ruggiero, et al.
Therapeutic Advances in Chronic Disease|May 20, 2024
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysisAnnemieke M Boot, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Pageof 23